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T cell receptors (TCRs) recognize peptides presented by MHC molecules (pMHC) on an
antigen-presenting cell (APC) to discriminate foreign from self-antigens and initiate adap-
tive immune responses. In addition,T cell activation generally requires binding of this same
pMHC to a CD4 or CD8 co-receptor, resulting in assembly of a TCR–pMHC–CD4 or TCR–
pMHC–CD8 complex and recruitment of Lck via its association with the co-receptor. Here
we review structural and biophysical studies of CD4 and CD8 interactions with MHC mol-
ecules and TCR–pMHC complexes. Crystal structures have been determined of CD8αα
and CD8αβ in complex with MHC class I, of CD4 bound to MHC class II, and of a com-
plete TCR–pMHC–CD4 ternary complex. Additionally, the binding of these co-receptors to
pMHC and TCR–pMHC ligands has been investigated both in solution and in situ at the T
cell–APC interface.Together, these studies have provided key insights into the role of CD4
and CD8 in T cell activation, and into how these co-receptors focus TCR on MHC to guide
TCR docking on pMHC during thymic T cell selection.
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INTRODUCTION
Adaptive immunity depends on specific recognition by an αβ T
cell receptor (TCR) of an antigenic peptide bound to a major
histocompatibility complex (pMHC) molecule on an antigen-
presenting cell (APC). However, TCR–pMHC interactions alone
do not efficiently trigger T cells, requiring the participation of the
co-receptors CD4 and CD8 (1–4). These transmembrane glyco-
proteins mark different T cell subsets. CD4 is expressed on Th1,
Th2, and Th17 helper cells, as well as on CD4 regulatory T cells
(Tregs); CD8 is expressed on cytotoxic T lymphocytes (CTLs) and
CD8 Tregs. CD4 and CD8 enhance T cell signaling by binding
MHC class II (CD4) or MHC class I (CD8) molecules on APCs.
The interaction of CD4 with MHC class II greatly reduces the
number of antigenic peptides required for T cell activation (5) and
substantially increases cytokine production by helper T cells (1).
Likewise, the CD8–MHC class I interaction enhances the antigen
sensitivity and response of cytotoxic T cells to pMHC ligands (6).
The principal role of the CD4 and CD8 co-receptors is to recruit
the Src tyrosine kinase p65lck (Lck) to the TCR–pMHC complex
following co-receptor binding to MHC, resulting in assembly of a
TCR–pMHC–CD4 or TCR–pMHC–CD8 ternary complex (7–10).
Recruitment of Lck occurs via its association with the cytoplasmic
tail of CD4 or CD8. The accompanying increase in the local con-
centration of Lck promotes phosphorylation of immunoreceptor
tyrosine activation motifs (ITAMs) in the cytoplasmic tails of CD3
subunits associated with the TCR in the TCR–CD3 complex, lead-
ing to the recruitment and activation of Zap-70. Activated Zap-70
phosphorylates LAT and SLP-76, which function as scaffolds to
recruit other signaling molecules to the downstream T cell signal-
ing apparatus that regulates T cell activation, proliferation, and
differentiation. The targeted delivery of Lck to TCR by CD4 or
CD8 during thymic selection is believed to impose MHC restric-
tion on the developing αβ TCR repertoire (11). In support of this
idea, αβ TCRs in mice lacking co-receptors and MHC are not
biased toward pMHC ligands, but instead display antibody-like
recognition specificities (12, 13).
This review focuses on structural and biophysical studies of
CD4 and CD8 interactions with MHC molecules. Crystal struc-
tures have been determined of CD8αα and CD8αβ in complex with
MHC class I, of CD4 bound to MHC class II, and, most recently, of
a complete TCR–pMHC–CD4 ternary complex. In addition, the
binding of these co-receptors to pMHC and TCR–pMHC ligands
has been investigated both in solution and in situ. Collectively,
these studies have provided critical insights into the role of CD4
and CD8 in T cell activation and in guiding TCR docking on
pMHC during T cell development.
INTERACTION OF CD8 WITH MHC CLASS I
CD8 exists as two isoforms, CD8αα and CD8αβ, which are
expressed on different cell types and appear to have different func-
tions. CD8ββ homodimers have also been reported, but these lack
MHC-binding activity and their significance is unknown (14).
Whereas CD8αα is found on γδ T cells, intestinal intraepithelial T
lymphocytes, and natural killer (NK) cells, CD8αβ is expressed on
αβ TCR thymocytes and CTLs. The function of CD8αα remains
obscure, but it has been implicated in the negative regulation of
intestinal intraepithelial T lymphocytes (15). By contrast, CD8αβ
is clearly required for positive selection of CD8+ T cells in the thy-
mus (16–18) and for activation of CD8+ T cells in the periphery
(19). In both CD8αα and CD8αβ, Lck associates with the CD8α
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chain. In addition, ligation of CD8αβ by MHC, in the absence of
TCR engagement, results in apoptosis of a proportion of double-
positive thymocytes, which may be a mechanism for removing
thymocytes that have failed positive selection (20).
Fluorescence resonance energy transfer experiments have
shown that, during T cell activation, the TCR binds initially to
pMHC, and that CD8 then binds to the same pMHC as the TCR,
leading to formation of a TCR–pMHC–CD8 complex (21). This
order of engagement ensures that the specific TCR–pMHC interac-
tion dominates T cell recognition. As measured by surface plasmon
resonance (SPR), CD8 binds very weakly to MHC class I in both
mouse and human, with little influence of the MHC-bound pep-
tide (21–23). In the mouse, the average binding affinity for CD8αβ
(K D∼50µM) is similar to that for CD8αα (∼70µM), with some
variation depending on the particular MHC class I allele. The
human CD8–MHC class I interaction is weaker still, averaging
∼150µM (24–26). In both cases, these affinities are 10- to 100-fold
lower than for most TCR–pMHC interactions.
In overall agreement with these SPR results, in situ measure-
ments of the mouse CD8–MHC class I interaction gave an affinity
several orders of magnitude lower than that of TCR for pMHC
(27). These experiments used a micropipette adhesion frequency
assay to measure the adhesion kinetics of live T cells interact-
ing with pMHC ligands presented on surrogate APCs. The two-
dimensional (2D) binding parameters derived from this technique
are thought to more accurately reflect biological interactions in
membranes than the three-dimensional (3D) parameters derived
from SPR, in which fluid-phase receptors and ligands are removed
from their cellular environment (28).
Although the affinity of CD8 for MHC class I is weak, recent
2D affinity measurements support the idea that CD8 contributes
significantly to stabilizing the TCR–pMHC interaction at the T
cell–APC interface (9). These experiments revealed that the TCR–
pMHC–CD8 trimolecular interaction generates synergy over the
simple sum of the individual TCR–pMHC and pMHC–CD8
interactions, and that this cooperativity amplifies peptide dis-
crimination. Thus, in addition to its primary role of recruiting
Lck to the TCR–pMHC complex, a secondary function of CD8
is to reinforce TCR binding to the pMHC ligand. Whether the
CD4 co-receptor also promotes cooperative binding remains to be
determined.
The micropipette adhesion frequency assay also revealed that
the kinetics of the TCR–pMHC–CD8 trimolecular interaction at
the T cell membrane proceeds in two stages (9). The first con-
sists of TCR-dominant binding to agonist pMHC. This triggers a
second stage involving an upregulation of CD8-dependent adhe-
sion after a 1 s delay. The second stage requires Lck kinase activity
to initiate CD8 binding to the same pMHC ligand engaged by
the TCR, generating synergy. It remains to be established whether
the TCR–pMHC–CD4 trimolecular interaction involves a similar
sequence of events.
STRUCTURES OF CD8 BOUND TO MHC CLASS I
CD8αβ is a heterodimeric type I transmembrane glycoprotein,
whose α and β chains are each composed of an immunoglobulin
(Ig)-like domain connected by a long stalk to a transmembrane
domain and a cytoplasmic tail, with Lck bound to the CD8α tail.
By contrast, the CD8αα homodimer comprises only the α chain.
Four structures of CD8αα or CD8αβ bound to MHC class I mole-
cules have been reported: (1) the complex between human CDαα
and HLA-A∗0201 (29); (2) the complex between human CD8αα
and HLA-A∗2402 (30); (3) the complex between mouse CD8αα
and H-2Kb (31); and (4) the complex between mouse CD8αβ and
H-2Dd (23).
In the CD8αβ–H-2Dd complex (23), the CD8αβ heterodimer
contacts only the α3 domain of the MHC class I heavy chain
(Figure 1A). By contrast, CD8αα also contacts the α2 domain
and β2-microglobulin (β2m) in the CDαα–HLA-A∗0201 (29),
CD8αα–HLA-A∗2402 (30), and CD8αα–H-2Kb complexes (31)
(Figure 1C). The CD8β subunit occupies a position equivalent
to that of the CD8α1 subunit in the three CD8αα–MHC class I
structures, which places CD8β proximal to the T cell membrane.
The CD8α subunit of CD8αβ is located in the same position as the
CD8α2 subunit, distal from the T cell and near the C-terminus of
the MHC class I α3 domain (Figures 1A,C). Nearly all MHC class I
residues that mediate key interactions with CD8αα or CD8αβ are
non-polymorphic, which explains the largely allele-independent
nature of CD8 binding.
For both CD8αα and CD8αβ, the main binding interac-
tion is with a protruding loop in the α3 domain of the MHC
class I molecule (CD loop), corresponding to residues 220–228
(Figures 1B,D). This loop is flexible in the absence of CD8, but is
stabilized by CD8 binding. In the CD8αα–MHC class I structures,
the two CDR3-like loops of the CD8α subunits clamp onto the
central β-turn portion of the CD loop in an antibody-like manner,
as do the two CDR3-like loops of CD8αβ (23, 29–31). In addi-
tion, CD8αα contacts the α2 domain and β2m through its CD8α1
subunit, whereas the corresponding CD8β subunit of CD8αβ con-
tacts only α3. Of particular note in the CD8αβ–H-2Dd complex is
Gln226 of H-2Dd, a highly conserved residue among MHC class I
alleles and the only one that interacts with both CD8α and CD8β
(Figure 1B).
ROLE OF THE CD8 STALK REGION IN CO-RECEPTOR
FUNCTION
The Ig-like domains of CD8α and CD8β are tethered to the T
cell membrane by long stalk regions comprising ∼45 residues for
CD8α and ∼35 residues CD8β (32). These stalk regions, which
are rich in threonine, serine, and proline residues, are heavily O-
glycosylated at multiple sites in all species studied (33). The stalk of
CD8αβ undergoes developmentally programed O-glycan modifi-
cation controlled by the sialyltransferase ST3 Gal-I,which catalyzes
addition of sialic acid to core 1 O-linked glycans (34). In particu-
lar, immature CD4+CD8+ thymocytes exhibit lower levels of CD8
sialylation than mature thymocytes (32, 34, 35). Decreased sialyla-
tion of the CD8αβ stalk was found to markedly increase the affinity
of CD8 for MHC class I, as measured by MHC tetramer binding,
thereby affecting T cell selection (34, 35). Enhanced CD8αβ bind-
ing at the CD4+CD8+ stage facilitates elimination of autoreactive
T cells in the thymus. However, once a double-positive thymo-
cyte has differentiated to the CD8+ stage, O-glycan sialylation of
the CD8αβ stalk reduces co-receptor affinity for pMHC, requir-
ing a stronger TCR–pMHC interaction for T cell activation in the
periphery (34, 35).
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FIGURE 1 | Comparison of CD8αβ–H-2Dd and CD8αα–H-2Kb complexes.
(A) Ribbon diagram of the CD8αβ–H-2Dd complex (Protein Data Bank
accession code 3DMM) (23). MHC α chain, yellow; β2m, gray; CD8α, cyan;
CD8β, green. (B) Interaction between the CDR-like loops of CD8αβ and the
H-2Dd α3 CD loop. The side chains of contacting residues are shown in
ball-and-stick representation with carbon atoms in magenta, nitrogen atoms in
blue, and oxygen atoms in red. Hydrogen bonds are drawn as dotted black
lines. (C) Ribbon diagram of the CD8αα–H-2Kb complex (1BQH) (31). MHC α
chain, yellow; β2m, gray; CD8α1, pink; CD8α2, cyan. (D) Interaction between
the CDR-like loops of CD8αα and the H-2Kb α3 CD loop.
The structural basis for reduced CD8αβ affinity for MHC class
I upon sialylation of the stalk region is unknown. One possibil-
ity is that sialylation alters the association or orientation of the
Ig-like domains of the CD8αβ heterodimer, reducing its capacity
to bind MHC class I (34). However, Merry et al. (36) found that
sialylation had little or no effect on the overall structure of CD8,
insofar as sialylated and non-sialylated forms of soluble CD8αα
exhibited indistinguishable hydrodynamic properties. This sug-
gests that the results of Moody et al. (34) and Daniels et al. (35)
might be explained by avidity effects arising from aggregation of
unsialylated CD8 on the T cell surface that increase MHC tetramer
binding (36).
Irrespective of the underlying mechanism, the finding that
developmentally regulated glycosylation of the CD8αβ stalk can
modulate MHC binding at the cell surface demonstrates that the
stalk has a specialized role in co-receptor function, beyond sim-
ply attaching the MHC-binding domains to the T cell membrane.
The long CD8αβ stalk may also allow a possible cis interaction
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between CD8 and MHC class I expressed on the same T cell (37),
in addition to the established trans interaction between CD8 and
MHC class I expressed on different cells. Interestingly, the stalk
regions of other immune system receptors have also been recently
found to play prominent roles in receptor function. For example,
the long stalk regions of Ly49 NK cell receptors enable binding to
MHC class I in cis or trans configurations (38). Additionally, the
stalk domain of the activating NK receptor NKp30 is critical for
NK cell killing and may contribute directly to binding its tumor
cell ligand B7-H6 (39).
No 3D structural information is available for the stalk regions of
CD8αβor CD8αα, since the stalks, when included in the constructs
used for protein expression, were mostly or entirely disordered in
the CD8–MHC class I crystal structures (23, 29–31). Although
this has been interpreted to mean that that the CD8 stalk is highly
flexible, it should be emphasized that the stalks completely lacked
glycosylation because the CD8 proteins were produced in bacteria.
However, there is biophysical evidence that O-glycosylation may
significantly restrict the flexibility of the stalks. Studies of mucins
have demonstrated that O-glycans stiffen polypeptides through
steric interactions between peptide-linked N -acetylgalactosamine
residues and adjacent peptide residues (40, 41). Moreover, O-
glycans in the CD8 stalk polypeptides were found to reduce the
overall extension of the stalk from a theoretical maximum of 3.4 Å
per residue to 2.6 Å per residue, indicating rigidification (36, 42).
Therefore, O-glycosylation may limit the mobility of the CD8 head
group relative to the T cell membrane, an important consideration
in evaluating co-receptor interactions with TCR–pMHC during
thymic selection and peripheral antigen recognition, as discussed
below.
STRUCTURES OF CD4 BOUND TO MHC CLASS II
CD4 is a monomeric type I transmembrane glycoprotein consist-
ing of four Ig-like extracellular domains connected by a short stalk
to a transmembrane domain and a cytoplasmic tail that interacts
with Lck. CD4 binds MHC class II with exceptionally low affinity
compared to all other leukocyte cell–cell recognition molecules
characterized to date, whose K Ds typically fall in the 1–100µM
range, as measured by SPR (43, 44). For the CD4–MHC class II
interaction, K Ds have been estimated to range from∼200µM (for
human CD4 binding to mouse MHC class II) (45) to>2 mM (for
human CD4 binding to human MHC class II) (43). These affinities
are substantially weaker than those for CD8–MHC class I interac-
tions, which range from ∼10µM (for mouse CD8αβ binding to
H-2Dd) (23) to ∼150µM (for human CD8αα binding to HLA-
A∗0201) (26). Presumably, evolution has calibrated the affinity of
CD4 for MHC class II to enable peripheral T cells to respond effi-
ciently to the very low abundance of foreign pMHC molecules on
APCs (sensitivity), yet avoid activation by the far greater num-
ber of self-pMHC molecules (discrimination), which could cause
autoimmunity.
The ability of CD4 to recognize highly polymorphic MHC class
II molecules is central to its function as a co-receptor (1). In
humans, MHC class II molecules are encoded by three separate
loci (HLA-DR, -DQ, and -DP), while in mice they are encoded
by two loci (I-A and I-E). For HLA-DR, most variability derives
from the β-chain, with>700 known alleles at the population level,
whereas there are only three α-chain variants. In contrast, both
α- and β-chains of HLA-DQ and -DP are polymorphic (46). Two
structures of CD4 bound to MHC class II molecules have been
reported: (1) the complex between human CD4 (domains D1 and
D2) and mouse I-Ak to 4.3 Å resolution (47); and (2) the complex
between human CD4 (domains D1 and D2) and human HLA-
DR1 to 2.4 Å resolution (48). These structures readily explain the
ability of CD4 to recognize multiple MHC class II alleles.
The CD4–I-Ak and CD4–HLA-DR1 complexes display simi-
lar overall topologies, although only the higher-resolution CD4–
HLA-DR1 structure permitted an atomic-level description of the
CD4–MHC class II interface. In both complexes, CD4 binds MHC
class II through its membrane-distal D1 domain, which contacts
the membrane-proximal α2 and β2 domains of the MHC class
II molecule (Figure 2A). CD4 uses two discontinuous regions to
engage MHC class II in a concavity formed by the α2 and β2
domains (Figure 2B). The first region, composed of β-strands C′
and C′′, exclusively contacts the β2 domain. The second region,
comprising a short 310 helix within the loop connecting β-strands
D and E, binds solely to the α2 domain.
Figure 2C shows sequence alignments of the α- and β-chains of
selected HLA-DR, -DP, and -DQ alleles in the regions where HLA-
DR1 contacts CD4. For the β-chains, 11 of 12 CD4-contacting
residues are absolutely conserved in these human MHC class II
molecules, and 1 is conservatively substituted (Val116Ile in HLA-
DQ). For the α-chains, all three CD4-contacting residues (Glu88,
Thr90, Leu176) are invariant across human MHC class II alleles.
Hence, the remarkable cross-reactivity of CD4 is attributable to the
targeting of non-polymorphic residues in the concavity formed by
the α2 and β2 domains of HLA-DR, -DP, and -DQ. For I-Ak, 11
of 14 CD4-contacting residues are identical to those of HLA-DR1,
while for I-Ek 12 of 14 are identical (Figure 2C). All non-identical
residues are conservatively substituted in both molecules. There-
fore, CD4 almost certainly engages all human and mouse MHC
class II molecules in the same manner as it does HLA-DR (48).
STRUCTURE OF A TCR–pMHC–CD4 TERNARY COMPLEX
The low affinity of CD4 for MHC class II presented a major techni-
cal obstacle to crystallizing a TCR–pMHC–CD4 ternary complex.
To overcome this obstacle, in vitro directed evolution by yeast sur-
face display was used to increase the affinity of CD4 for MHC class
II (49). Affinity maturation by yeast display relies on expression
of a library of mutants on the surface of yeast, followed by selec-
tion of variants with improved affinity (50). The D1 domain of
human CD4 was subjected to in vitro random mutagenesis, and
the resulting mutant library was displayed on yeast by fusion to
agglutinin protein Aga2p (48). Because CD4 binds MHC class II
very weakly (43, 45), the CD4 library was sorted by flow cytome-
try using HLA-DR1 tetramers, rather than monomers, to increase
the avidity of the selecting ligand. In this way, a CD4 mutant that
bound HLA-DR1 with K D= 9µM was isolated, compared with
no detectable binding for wild-type CD4, even at high concen-
trations (400µM). The CD4 mutant exhibited similar affinity for
HLA-DR4 (K D= 10µM), in agreement with the ability of CD4 to
recognize all HLA-DR alleles, as discussed above.
The affinity-matured CD4 mutant contained two substitu-
tions in the D1 domain: Gln40Tyr and Thr45Trp. In the mutant
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FIGURE 2 | Structure of a human CD4–MHC class II complex. (A) CD4
(green) contacts the α2 (yellow) and β2 (gray) domains of HLA-DR1
through its D4 domain (3S4S) (48). The MHC-bound peptide is red. (B)The
CD4–HLA-DR1 binding interface. The two regions of CD4 (residues 35–48
and 59–63) that contact HLA-DR1 are shown in stick representation with
carbon atoms in green, oxygen atoms in red, and nitrogen atoms in blue.
The molecular surface of HLA-DR1 that interacts with CD4 is depicted
with the α2 domain in yellow and the β2 domain in gray. (C) Sequence
alignment of the CD4-contacting regions of the α- and β-chains of different
human and mouse MHC class II alleles. Residues that contact CD4 in the
CD4–HLA-DR1 structure are marked with triangles. White characters on a
red background show residues that are strictly conserved across human or
mouse MHC class II molecules. Black characters on a tan background are
conservatively substituted residues. (D) Close-up view of the interactions
between an affinity-matured CD4 mutant (green) and the HLA-DR1 β2
domain (gray). The side chains of interacting residues are shown in
ball-and-stick representation with carbon atoms in cyan (CD4) or yellow
(HLA-DR1), oxygen atoms in red, and nitrogen atoms in blue. The mutated
Tyr40 and Trp45 residues of CD4 are in magenta. Hydrogen bonds are
drawn as dotted black lines.
CD4–HLA-DR1 structure (48), CD4 Trp45 is located at the
center of the interface with HLA-DR1, where its bulky side
chain makes multiple hydrophobic contacts with DR1 β2 Val143
(Figure 2D). Similarly, CD4 Tyr40 is surrounded by apolar
DR1 β2 residues Leu114, Val116, Leu158, and Met160, result-
ing in increased hydrophobic interactions at the mutation site.
Together, the Gln40Tyr and Thr45Trp mutations improved shape
and chemical complementarity with HLA-DR1, thereby stabilizing
the CD4–HLA-DR1 complex.
The enhanced affinity of this CD4 mutant made possible
the crystallization and structure determination of a complete
TCR–pMHC–CD4 ternary complex involving a human autoim-
mune TCR (MS2-3C8), a self-peptide from myelin basic pro-
tein (MBP) bound to HLA-DR4, and CD4 (49) (Figure 3A).
The TCR–pMHC–CD4 complex resembles a pointed arch in
which both TCR and CD4 are tilted rather than oriented ver-
tically. The TCR and CD4 molecules each make an angle of
∼65° with the T cell surface. The apex of the arch is formed
by the α2 and β2 domains of HLA-DR4 and the D1 domain of
CD4. MS2-3C8 engages MBP via the canonical docking mode
of αβ TCRs (51), in which the TCR adopts a central diagonal
orientation over pMHC (52, 53). There are no direct contacts
between TCR and CD4 (Figure 3A), in agreement with an earlier
prediction (47).
The CD4 molecule bound to TCR–pMHC retains the over-
all extended conformation observed in different crystal forms of
unbound CD4 (54), with some hinge-like variability at the D2–D3
junction. The limited segmental flexibility of CD4 implies that any
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FIGURE 3 | Comparison ofTCR–pMHC–CD4 andTCR–pMHC–CD8 ternary
complexes. (A) Crystal structure of a TCR–pMHC–CD4 complex
(MS2-3C8–MBP–DR4–CD4) oriented as if the TCR and CD4 molecules are
attached to the T cell at the bottom and the MHC class II molecules is
attached to an opposing APC at the top (3T0E) (49). TCR α chain, blue; TCR β
chain, cyan; MHC α chain, yellow; MHC β chain, gray; CD4, red. (B)
Hypothetical model of the TCR–pMHC–CD8 complex. The model was
constructed by superposing the CD8αβ–H-2Dd complex (3DMM) (23) onto a
TCR–H-2Db complex (3PQY) through the MHC class I molecule. A portion of
the CD8β stalk region was visible in the crystal structure and points toward
the T cell membrane. The C-termini of the CD8α and CD8β chains are labeled.
The orientation of the TCR–pMHC complex is the same as in (A). TCR α chain,
blue; TCR β chain, cyan; MHC α chain, yellow; β2m, gray; CD8α, green; CD8β,
violet.
significant variations in overall complex architecture must arise
from differences in TCR docking on pMHC.
The absence of direct contacts between TCR and CD4 explains
how these molecules can simultaneously, yet independently, bind
to pMHC. Importantly, the wide separation (∼70 Å) between the
membrane-proximal TCR Cα/Cβ module and CD4 D4 domain
provides ample room for the placement of TCR-associated CD3εγ,
εδ, and ζζ subunits (Figure 4A), which transmit activation signals
to the T cell (55). Although no crystal structure is available for the
TCR–CD3 complex, mutational studies have identified docking
sites for the ectodomains of CD3εδ and CD3εγ,which interact with
the TCR through adjacent Cα DE and Cβ CC′ loops, respectively
(56–58). Based on this information, CD3εγ and CD3εδ would be
situated inside the TCR–pMHC–CD4 arch, wedged between the
TCR and T cell membrane (Figure 4A). In the organization of
the TCR–CD3 complex proposed by Fernandes et al. (58), only
CD3γ and CD3δ contact the TCR, whereas CD3ε projects away
from the receptor. The relative proximity of CD3ε to CD4 in the
TCR–pMHC–CD4 complex, compared to CD3γ or CD3δ, may
confer preference to CD3ε in the ITAM phosphorylation cascade
upon Lck recruitment by CD4 (Figure 4A).
The ectodomain of CD3ζ, which is only nine amino acids in
length, has not been implicated in interactions with the TCR
ectodomain, and so is not shown in Figure 4A. However, muta-
tional analysis of the transmembrane regions of TCR and CD3
subunits has established that CD3ζζ is associated with TCRα in
the T cell membrane (59).
It has been proposed that, in resting T cells, CD3ε ITAMs are
sequestered in the membrane, and that activation results in ITAM
exposure to Src kinases (60). If so, the TCR–pMHC–CD4 structure
suggests a possible mechanism by which this may occur. If the TCR
shifts from an upright to a tilted orientation upon formation of
the TCR–pMHC–CD4 complex (Figure 3A), this movement could
potentially drive the CD3 ectodomains, situated inside the TCR–
pMHC–CD4 arch, into the T cell membrane. This in turn could
cause displacement of CD3ε ITAMs from the membrane and their
phosphorylation by Lck.
THE TCR–pMHC–CD4 COMPLEX AND MODELS FOR TCR
TRIGGERING
There is considerable controversy over the mechanism of TCR
triggering, and a variety of models have been proposed to explain
how pMHC binding to TCR initiates signaling across the T cell
membrane (55). Some of these models invoke dimerization (or
oligomerization) of CD4 (54), MHC (61), or TCR (57) as a means
of enhancing phosphorylation of CD3 ITAMs by increasing the
proximity of associated tyrosine kinases. The plausibility of these
models can be assessed in terms of the geometrical constraints
imposed by the TCR–pMHC–CD4 structure.
The structure of human CD4 D1–D4 in unbound form showed
that CD4 molecules form dimers through the D4 domain, at
least in the crystal (54). This observation suggested that D4–
D4-associated CD4 dimers might contribute to T cell activation
by cross-linking TCR–pMHC complexes (54, 62). However, the
TCR–pMHC–CD4 structure is incompatible with this idea. In a
hypothetical model constructed by superposing the TCR–pMHC–
CD4 structure onto the D4–D4-associated CD4 dimer, the distance
between the C-termini of the D4 domains and the T cell sur-
face is too far (∼40 Å) to be spanned by the eight-residue stalk
region of CD4 (49). Similarly, the finding that some HLA-DR
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FIGURE 4 | Orientation ofTCR and CD4 inTCR–pMHC–CD4 complexes.
(A)Top view of the MS2-3C8–MBP–DR4–CD4 complex (Figure 3A), as if
looking down on the T cell. The membrane-proximal TCR Cα/Cβ domains
and the CD4 D4 domain are depicted in surface representation. Other
domains and pMHC are omitted for clarity. TCR Cα, blue; TCR Cβ, green;
CD4 D4, pink. The proposed arrangement of the ectodomains of CD3εγ and
CD3εδ (58) is shown in relation to docking sites identified by mutational
analyses (56, 58): Cα DE loop (yellow) and Cβ CC′ loop (dark blue). The
Ig-like ectodomains of CD3εγ and CD3εδ are drawn as orange circles. In this
arrangement, only CD3γ and CD3δ contact the TCR. CD3ε projects away
from the TCR, toward CD4. (B) Bottom view of the MS2-3C8–MBP–
DR4–CD4 complex, as if looking up from inside the T cell. On the left side,
the C-termini of the extracellular portions of the α and β chains of TCR
MS2-3C8, as defined in the crystal structure (49), are indicated by blue and
green spheres, respectively. On the right side, the C-terminus of the
extracellular portion of CD4 in the complex with MS2-3C8 and HLA-DR4 is
marked by a red sphere labeled MS2-3C8. The right side also shows the
predicted position of the C-terminus of CD4 in 15 hypothetical ternary
complexes constructed using other TCR–pMHC class II structures [human:
HA1.7 (1JH8), Ob.1A12 (1YMM), 3A6 (1ZGL), E8 (2IAM), Hy.1B11 (3PL6),
G4 (4E41); SP3.4 (4GG6); Ani2.3 (4H1L); mouse: B3K506 (3C5Z), 2W20
(3C6L), YAe62 (3C60), 21.30 (3MBE); J806.B5 (3RDT); 2B4 (3QIB); 226
(3QIU)]. In each case, the C-terminus of CD4 is marked by a colored sphere
labeled with the name of the corresponding TCR. Autoimmune TCRs
(MS2-3C8, Ob.1A12, 3A6, Hy.1B11) are red; anti-foreign (HA1.7, B3K506,
2W20, 21.30, YAe62, SP3.4, Ani2.3, J805.B5, 2B4, 226) and anti-tumor
TCRs (E8, G4) are black. The TCR–pMHC–CD4 complexes were modeled by
superposing each TCR–pMHC class II structure onto the MS2-3C8–MBP–
DR4–CD4 complex through the Cα/Cβ domains of the TCRs. The
anti-foreign and anti-tumor TCRs (black spheres) form a cluster that mostly
excludes the autoimmune TCRs (red spheres), with Hy.1B11, MS2-3C8, and
3A6 on one side of the cluster and Ob.1A12 on the other.
molecules crystallize as dimers (61, 63) suggested a mechanism
for T cell triggering in which an MHC class II dimer cross-links
two TCRs. However, the CD4-binding site on HLA-DR4 almost
completely overlaps the putative HLA-DR dimerization site, which
would preclude formation of such MHC class II dimers (49).
Recently, it was proposed that TCRs can dimerize in the
T cell membrane via Cα–Cα interactions, and that the result-
ing juxtaposition of two TCR–pMHC complexes facilitates sig-
naling through the membrane (57, 64). Consistent with this
model, the putative site of Cα–Cα dimerization is on the out-
side of the TCR–pMHC–CD4 arch, opposite the sites mediating
TCR–CD3 interactions (Figure 4A) (49). As such, CD4 would
not interfere sterically with TCR dimerization through the Cα
domain. However, a survey of 22 TCR–pMHC crystal struc-
tures failed to reveal any Cα–Cα contacts consistent with bio-
logically relevant TCR dimerization (65). More tellingly, the Cα
domain contains two conserved N -linked glycans at positions that
would preclude the hypothesized TCR dimerization via Cα–Cα
interactions.
Several recent studies have demonstrated that physical force
applied to the TCR–CD3 complex can activate T cells (66–68).
This finding has led to the concept of the TCR as an anisotropic
mechanosensor that converts mechanical energy into a biochem-
ical signal upon specific pMHC ligation as a T cell moves over
APCs during immune surveillance (66). While it is unknown how
pulling on the TCR–CD3 complex can be transduced to the T
cell interior, one possibility is that pMHC binding leads to a con-
formational change in the CD3 cytoplasmic tails, allowing ITAM
phosphorylation by Src kinases. This process may be facilitated by
the CD4 (or CD8) co-receptor, whose binding to the TCR–pMHC
complex could promote dissociation of CD3 ITAMs from the cyto-
plasmic side of the T cell membrane and their exposure to Lck, as
discussed above.
CO-RECEPTORS AND TCR–pMHC DOCKING ORIENTATION
The TCR–pMHC–CD4 complex provides a basis for understand-
ing how the CD4 and CD8 co-receptors focus TCR on MHC to
guide TCR docking on pMHC during thymic T cell selection.
Structural studies of numerous (>25) TCR–pMHC complexes
have demonstrated remarkable similarities in the overall topol-
ogy of TCR binding to pMHC, regardless of MHC class I or class
II restriction (52, 53). Typically, the TCR is positioned diagonally
over the center of the composite surface created by the peptide
and the MHC α-helices that flank the peptide-binding groove,
with Vα situated over the N-terminal half of the peptide, and Vβ
over the C-terminal half, although the exact angle and pitch of
TCR engagement vary.
Two competing (though not mutually exclusive) hypotheses
have been proposed to explain this roughly conserved diagonal
binding mode. The first maintains that co-evolution of TCR and
MHC genes has led to specific interaction motifs between the
germline-encoded CDR1 and CDR2 loops of TCRs and the α-
helices of MHC proteins (53, 69–73). According to the second
hypothesis, TCR docking topology is guided by the CD4 and CD8
co-receptors during T cell development in order to achieve intra-
cellular juxtaposition of co-receptor-bound Lck with CD3 ITAMs
(11–13, 49, 71, 72, 74, 75). According this view, it is the need for co-
receptor function during thymic T cell selection that restricts the
geometry of TCR–pMHC recognition and eliminates from posi-
tive selection CD4+CD8+ double-positive thymocytes expressing
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TCRs unable to engage pMHC in a manner that generates a signal
to induce maturation.
The arch-shaped TCR–pMHC–CD4 complex establishes
anchor points for TCR and CD4 on the T cell membrane, thereby
imposing constraints on the orientation of CD3 relative to Lck
associated with CD4 on the cytoplasmic side of the membrane.
Figure 4B shows the position of the C-terminus of CD4 observed
in the complex with TCR MS2-3C8 and HLA-DR4, as well as
the predicted position of the C-terminus of CD4 in hypothet-
ical ternary complexes constructed using 15 other TCR–pMHC
class II structures, both human and mouse. Except for the human
autoimmune TCR Ob.1A12 (76), the C-termini of CD4 in these
modeled complexes are grouped in a loose cluster that includes the
C-terminus of CD4 in the MS2-3C8–MBP–DR4–CD4 complex.
Differences in the position of the CD4 membrane anchor point
are attributable to variations in the diagonal docking topology
of the TCR–pMHC complexes, which places CD3εγ and CD3εδ
inside the TCR–pMHC–CD4 arch, opposite CD4 (Figure 4A).
If the TCR–pMHC docking polarity were reversed (i.e., Vα over
the C-terminus of the peptide and Vβ over the N-terminus),
CD3εγ and CD3εδ would be positioned outside, rather than
inside, the TCR–pMHC–CD4 arch. The much greater distance
between CD4-bound Lck and CD3 ITAMs would likely hinder
ITAM phosphorylation by Lck, thereby preventing positive selec-
tion of T cells bearing TCRs with the reversed polarity, or their
activation in the periphery. We therefore propose that the diag-
onal docking topology of TCR–pMHC complexes reflects not
only genetically encoded interactions with MHC (53, 69), but
also the requirement to form a ternary complex with the CD4
or CD8 co-receptor that is geometrically competent to deliver
a maturation signal to CD4+CD8+ thymocytes during T cell
selection.
Nonetheless, some flexibility must exist within the overall sig-
naling complex to accommodate variations in TCR–pMHC dock-
ing geometry that affect the location of anchor points for TCR and
CD4 on the T cell membrane (Figure 4B). Given the rigidity of the
CD4 ectodomain (49), this flexibility most likely resides in inter-
actions involving the flexible cytoplasmic tails of CD3 and CD4
with Lck, which itself can adopt multiple conformations (77). The
flexibility of the cytoplasmic domains of CD3 is supported by cir-
cular dichroism analysis and disorder prediction algorithms (78).
By both methods, the cytoplasmic domains of CD3ζ, CD3ε, CD3γ,
and CD3δ were found to be intrinsically unstructured, random-
coil proteins in both monomeric and oligomeric states, and in the
presence or absence of lipids.
Of the 16 TCRs in Figure 4B, 4 are autoimmune (Hy.1B11,
MS2-3C8, 3A6, Ob.1A12). These TCRs, which were isolated from
different multiple sclerosis patients, recognize MBP self-peptides
bound to HLA-DQ1 (Hy.1B11), HLA-DR4 (MS2-3C8), HLA-
DR2a (3A6), or HLA-DR2b (Ob.1A12). T cells expressing these
four autoimmune TCRs escaped negative selection in the thymus
yet still retained the ability to productively engage self-antigens
in the periphery. The remaining 12 TCRs recognize foreign anti-
gens, such as influenza virus hemagglutinin (HA1.7) and moth
cytochrome c (2B4, 226), or tumor antigens (G4, E8). In Figure 4B,
the C-termini of CD4 in the 16 TCR–pMHC–CD4 complexes
sweep out an arc of ∼70°, with autoimmune TCRs Ob.1A12 and
Hy.1B11 at the two extremities. Strikingly, the 12 anti-foreign or
tumor-specific TCRs form a relatively tight cluster that effectively
excludes the four autoimmune TCRs, with Ob.1A12 on one side of
the cluster and Hy.1B11, MS2-3C8, and 3A6 on the other. Because
CD4-bound Lck would be positioned differently with respect to
CD3 ITAMs inside the T cell, phosphorylation of CD3 ITAMs
by Lck may be differentially affected in TCR–pMHC–CD4 com-
plexes involving anti-foreign versus autoimmune TCRs. In this
way, the geometry of the TCR–pMHC–CD4 complex could modu-
late TCR signaling, and thereby directly impact T cell development
and autoimmunity.
IMPLICATIONS FOR THE TCR–pMHC–CD8 TERNARY
COMPLEX
Although no structure of a TCR–pMHC–CD8 ternary complex
has been reported, a hypothetical model may be constructed by
superposing the CD8αβ–H-2Dd complex (23) onto a representa-
tive TCR–pMHC class I complex through the shared MHC class
I molecule (Figure 3B). The model is consistent with the idea
that the shorter CD8β stalk helps orient the cytoplasmic domains
of CD8αβ for their role in signal transduction (23, 79). How-
ever, in the absence of structural information on the CD8 stalk,
the model cannot establish anchor points for TCR and CD8 on
the T cell membrane, as did the TCR–pMHC–CD4 structure
(Figure 3A). While the TCR–pMHC–CD8 complex is probably
not as conformationally constrained as the TCR–pMHC–CD4
complex, O-glycosylation of the CD8 stalk likely restricts its flex-
ibility (36, 42), as discussed above. By limiting the mobility of the
MHC-binding head group of CD8 in this way, O-glycosylation
would impose constraints on the orientation of CD3 subunits
relative to CD8-bound Lck, as does the rigid CD4 structure
(Figure 4A).
Even with O-glycosylation, the proline-rich CD8 stalk is likely
to be less stiff than the four tandem Ig-like domains of CD4.
This flexibility may help compensate for variations in TCR–pMHC
docking geometry to facilitate intracellular juxtaposition of CD8-
bound Lck with CD3 ITAMs. The cytoplasmic tails of the CD3 sub-
units would provide additional flexibility within the overall TCR–
pMHC–CD8 signaling complex, just as in the TCR–pMHC–CD4
complex.
FUTURE DIRECTIONS
Much more is known about the biophysics of CD8 interactions
with TCR–pMHC at the T cell–APC interface than in the case
of CD4. For example, whereas in situ studies have demonstrated
that TCR and CD8 bind cooperatively to pMHC, and that this
synergy amplifies peptide discrimination (9), there is no compa-
rable information for CD4. Conversely, whereas the structure of
a TCR–pMHC–CD4 complex has been reported (49), that of a
TCR–pMHC–CD8 complex remains to be determined.
Until now, most studies of autoimmunity have emphasized
reduced TCR affinity for self-pMHC as the main reason autore-
active T cells sometimes escape negative selection in the thymus
(80). However, it is also possible that the altered docking topolo-
gies observed in autoimmune TCR–pMHC complexes (81) may
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modulate T cell signaling by altering interactions with CD4 or
CD8. In fact, autoimmune TCRs appear to segregate from anti-
foreign TCRs in terms of the geometry of the corresponding
TCR–pMHC–CD4 ternary complexes (Figure 4B). This hypoth-
esis clearly merits further investigation, particularly in view of an
emerging appreciation for the role of TCR docking geometry on
T cell signaling (49, 71).
The TCR–pMHC–CD4 structure, in conjunction with muta-
tional data on TCR–CD3 ectodomain interactions, suggests that
CD3εγ and CD3εδ are located under the TCR–pMHC–CD4 arch,
facing CD4 (Figure 4A). However, the current reality is that we
only have nebulous ideas about the molecular architecture of
the TCR–CD3 complex. Direct structural analysis of the TCR–
CD3 complex will be required to establish anchor points for CD3
and CD4 on the T cell membrane. This information, combined
with the known pairings of the transmembrane helices of the
TCR and CD3 chains from mutational analysis (TCRα–CD3εδ,
TCRα–CD3ζζ, and TCRβ–CD3εγ) (59), will reveal the intracellu-
lar organization of CD3 ITAMs relative to each other, and relative
to Lck bound to the CD4 or CD8 co-receptor.
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